Catalyst Wire Dossier Catalyst Wire Dossier

HC022 injection

· HC Biopharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HC022 injection, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE [Phase 1]

See pricing